Gossypol

Gossypol is a lipid of Prenol Lipids (PR) class. Gossypol is associated with abnormalities such as Paralytic Ileus, PARKINSON DISEASE, LATE-ONSET, Fibrillation, Hepatic necrosis and Lymphopenia. The involved functions are known as Atrophic, Ulcer, Necrosis, Apoptosis and antagonists. Gossypol often locates in Mucous Membrane, Epithelium, Blood, Microsomes, Liver and Autophagic vacuole. The associated genes with Gossypol are BCL2A1 gene, BCL2 gene, Transgenes, IGH@ gene cluster and Bax protein (53-86). The related lipids are Promega, proteoliposomes, Phosphatidylserines and Liposomes. The related experimental models are Transgenic Model and Xenograft Model.

Cross Reference

Introduction

To understand associated biological information of Gossypol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Gossypol?

Gossypol is suspected in Severe Combined Immunodeficiency, Aortic Valve Insufficiency, PARKINSON DISEASE, LATE-ONSET, Infertility, CLEFT LIP, CONGENITAL HEALED, Pulmonary Fibrosis and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Gossypol

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Cattle Diseases D002418 24 associated lipids
Infertility, Male D007248 11 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Testicular Diseases D013733 15 associated lipids
Lymphoma, Large B-Cell, Diffuse D016403 13 associated lipids
Melanoma D008545 69 associated lipids
Weight Gain D015430 101 associated lipids
Abnormalities, Drug-Induced D000014 10 associated lipids
Glioma D005910 112 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Leukemia P388 D007941 43 associated lipids
Per page 10 20 50 100 | Total 52

PubChem Associated disorders and diseases

What pathways are associated with Gossypol

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Gossypol through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Gossypol?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Gossypol?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Gossypol?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Gossypol?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Gossypol?

Xenograft Model

Xenograft Model are used in the study 'Gossypol induces apoptosis by activating p53 in prostate cancer cells and prostate tumor-initiating cells.' (Volate SR et al., 2010), Xenograft Model are used in the study 'Sorafenib sensitizes (-)-gossypol-induced growth suppression in androgen-independent prostate cancer cells via Mcl-1 inhibition and Bak activation.' (Lian J et al., 2012), Xenograft Model are used in the study 'Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa.' (Meng Y et al., 2008), Xenograft Model are used in the study '(-)-Gossypol suppresses the growth of human prostate cancer xenografts via modulating VEGF signaling-mediated angiogenesis.' (Pang X et al., 2011) and Xenograft Model are used in the study 'Gossypol induces death receptor-5 through activation of the ROS-ERK-CHOP pathway and sensitizes colon cancer cells to TRAIL.' (Sung B et al., 2010).

Transgenic Model

Transgenic Model are used in the study 'Bcl-2 antagonist apogossypol (NSC736630) displays single-agent activity in Bcl-2-transgenic mice and has superior efficacy with less toxicity compared with gossypol (NSC19048).' (Kitada S et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Gossypol

Download all related citations
Per page 10 20 50 100 | Total 1511
Authors Title Published Journal PubMed Link
pmid:22711315
Kanwar U et al. Gossypol-induced inhibition of glucose uptake in human ejaculated spermatozoa may be mediated by lipid peroxidation. 1990 Contraception pmid:2272185
Ignatova M et al. Quaternized chitosan-coated nanofibrous materials containing gossypol: preparation by electrospinning, characterization and antiproliferative activity towards HeLa cells. 2012 Int J Pharm pmid:22728261
Li HQ et al. Structure-based design of rhodanine-based acylsulfonamide derivatives as antagonists of the anti-apoptotic Bcl-2 protein. 2012 Bioorg. Med. Chem. pmid:22739087
Sun P et al. Action of db-cAMP on the bystander effect and chemosensitivity through connexin 43 and Bcl-2-mediated pathways in medulloblastoma cells. 2012 Oncol. Rep. pmid:22766741
Cuéllar A et al. Cholesterol side-chain cleavage and 11 beta-hydroxylation are inhibited by gossypol in adrenal cortex mitochondria. 1990 J. Steroid Biochem. Mol. Biol. pmid:2278843
Zheng DK et al. [Studies on the resolution of racemic gossypol. II. By chiral alpha-methylphenethylamine and alpha-methylbenzylamine]. 1990 Yao Xue Xue Bao pmid:2284966
Si YK et al. [Studies on the resolution of racemic gossypol. III. Study on the chemical and physical properties of the amino condensates of gossypol]. 1990 Yao Xue Xue Bao pmid:2284967
Zheng DK et al. [Studies on the resolution of racemic gossypol. IV. Use of threo (-) or (+)-1-(p-nitrophenyl)-1,3-dihydroxypropylamine-2 as the resolving agent]. 1990 Yao Xue Xue Bao pmid:2284968
Balakrishnan K et al. Bax and Bak are required for apogossypolone, a BH3-mimetic, induced apoptosis in chronic lymphocytic leukemia cells. 2013 Leuk. Lymphoma pmid:22866921
Hsiao WT et al. Involvement of Smac, p53, and caspase pathways in induction of apoptosis by gossypol in human retinoblastoma cells. 2012 Mol. Vis. pmid:22876131
Jackson RS et al. Sabutoclax, a Mcl-1 antagonist, inhibits tumorigenesis in transgenic mouse and human xenograft models of prostate cancer. 2012 Neoplasia pmid:22904682
Ionov M et al. Stability and antioxidant activity of gossypol derivative immobilized on N-polyvinylpyrrolidone. 2012 Int. J. Biol. Macromol. pmid:22910577
Wang AP et al. Effects of different sources and levels of dietary gossypol on gossypol residues in plasma and milk of lactating cows. 2012 J. Dairy Sci. pmid:22916918
Schuler MA Insect P450s: mounted for battle in their war against toxins. 2012 Mol. Ecol. pmid:22924794
Hedvat M et al. Selected approaches for rational drug design and high throughput screening to identify anti-cancer molecules. 2012 Anticancer Agents Med Chem pmid:22931411
Varadarajan S et al. A novel cellular stress response characterised by a rapid reorganisation of membranes of the endoplasmic reticulum. 2012 Cell Death Differ. pmid:22955944
Pond GR et al. Neutropenia as a potential pharmacodynamic marker for docetaxel-based chemotherapy in men with metastatic castration-resistant prostate cancer. 2012 Clin Genitourin Cancer pmid:23000202
Zbidah M et al. Gossypol-induced suicidal erythrocyte death. 2012 Toxicology pmid:23041711
Palle SR et al. RNAi-mediated Ultra-low gossypol cottonseed trait: performance of transgenic lines under field conditions. 2013 Plant Biotechnol. J. pmid:23078138
Hall C et al. Bcl-2 family of proteins as therapeutic targets in genitourinary neoplasms. 2013 Clin Genitourin Cancer pmid:23083798
Sarwar Gilani G et al. Impact of antinutritional factors in food proteins on the digestibility of protein and the bioavailability of amino acids and on protein quality. 2012 Br. J. Nutr. pmid:23107545
Vshivkov S et al. Capillary electrophoresis to quantitate gossypol enantiomers in cotton flower petals and seed. 2012 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:23122406
Senarisoy M et al. Gossypol interferes with both type I and type II topoisomerase activities without generating strand breaks. 2013 Cell Biochem. Biophys. pmid:23161103
Thakur A et al. Pan-Bcl-2 inhibitor AT-101 enhances tumor cell killing by EGFR targeted T cells. 2012 PLoS ONE pmid:23185240
Xin J et al. ApoG2 as the most potent gossypol derivatives inhibits cell growth and induces apoptosis on gastric cancer cells. 2013 Biomed. Pharmacother. pmid:23201009
Song T et al. 3-Thiomorpholin-8-oxo-8H-acenaphtho [1,2-b] pyrrole-9-carbonitrile (S1) derivatives as pan-Bcl-2-inhibitors of Bcl-2, Bcl-xL and Mcl-1. 2013 Bioorg. Med. Chem. pmid:23206987
Zhang Z et al. Novel soluble myeloid cell leukemia sequence 1 (Mcl-1) inhibitor (E,E)-2-(benzylaminocarbonyl)-3-styrylacrylonitrile (4g) developed using a fragment-based approach. 2013 Eur J Med Chem pmid:23220642
Wong FY et al. Combination therapy with gossypol reveals synergism against gemcitabine resistance in cancer cells with high BCL-2 expression. 2012 PLoS ONE pmid:23226540
Cho H et al. Poly(ethylene glycol)-block-poly(ε-caprolactone) micelles for combination drug delivery: evaluation of paclitaxel, cyclopamine and gossypol in intraperitoneal xenograft models of ovarian cancer. 2013 J Control Release pmid:23246471
Chatterjee TK and Bhatnagar RK Ca2(+)-dependent, ATP-induced conversion of the [3H]hemicholinium-3 binding sites from high- to low-affinity states in rat striatum: effect of protein kinase inhibitors on this affinity conversion and synaptosomal choline transport. 1990 J. Neurochem. pmid:2324736
Neild TO et al. Vasodilatation of arterioles by acetylcholine released from single neurones in the guinea-pig submucosal plexus. 1990 J. Physiol. (Lond.) pmid:2324984
Ahn JH et al. Defective autophagy in multidrug resistant cells may lead to growth inhibition by BH3-mimetic gossypol. 2013 J. Cell. Physiol. pmid:23254564
Karaca B et al. Combination of AT-101/cisplatin overcomes chemoresistance by inducing apoptosis and modulating epigenetics in human ovarian cancer cells. 2013 Mol. Biol. Rep. pmid:23269627
Warner TD Simultaneous perfusion of rat isolated superior mesenteric arterial and venous beds: comparison of their vasoconstrictor and vasodilator responses to agonists. 1990 Br. J. Pharmacol. pmid:2328405
Zhang Z et al. Fragment-based design, synthesis, and biological evaluation of N-substituted-5-(4-isopropylthiophenol)-2-hydroxynicotinamide derivatives as novel Mcl-1 inhibitors. 2013 Eur J Med Chem pmid:23314054
Ansari N et al. Quantitative 3D cell-based assay performed with cellular spheroids and fluorescence microscopy. 2013 Methods Cell Biol. pmid:23317907
Junco M et al. Substrate-dependent inhibition of protein kinase C by specific inhibitors. 1990 FEBS Lett. pmid:2332048
Goff DJ et al. A Pan-BCL2 inhibitor renders bone-marrow-resident human leukemia stem cells sensitive to tyrosine kinase inhibition. 2013 Cell Stem Cell pmid:23333150
Anderson MA et al. BH3 mimetic therapy: an emerging and promising approach to treating chronic lymphocytic leukemia. 2013 Leuk. Lymphoma pmid:23339446
Kannan A et al. Effect of feeding of calcium hydroxide-treated or vitamin E-supplemented cottonseed meal on plasma gossypol levels, blood parameters, and performance of Bikaneri lambs. 2013 Trop Anim Health Prod pmid:23345064
Wu DF and Reidenberg MM Stereoselective interaction between gossypol and rat plasma. 1990 Contraception pmid:2335102
Lin YC et al. Effect of gossypol on thyroid hormones in young female rats. 1990 Contraception pmid:2335106
Huo M et al. Suppression of LPS-induced inflammatory responses by gossypol in RAW 264.7 cells and mouse models. 2013 Int. Immunopharmacol. pmid:23352443
Cheng P et al. The novel BH-3 mimetic apogossypolone induces Beclin-1- and ROS-mediated autophagy in human hepatocellular carcinoma [corrected] cells. 2013 Cell Death Dis pmid:23392177
Dézsi L et al. Regulation of femoral vascular resistance by adenine nucleotides via endothelial and smooth muscle receptors. 1990 Acta Physiol Hung pmid:2339604
Ni Z et al. Natural Bcl-2 inhibitor (-)- gossypol induces protective autophagy via reactive oxygen species-high mobility group box 1 pathway in Burkitt lymphoma. 2013 Leuk. Lymphoma pmid:23398207
Prakash O and Khan F Development of method for three-point data estimation and SVR-QSAR model to screen anti cancer leads. 2013 Comb. Chem. High Throughput Screen. pmid:23410041
El-Nassan HB Advances in the discovery of kinesin spindle protein (Eg5) inhibitors as antitumor agents. 2013 Eur J Med Chem pmid:23434636
Liu Z et al. Protective effect of gossypol on lipopolysaccharide-induced acute lung injury in mice. 2013 Inflamm. Res. pmid:23435932